Table 2.
Characteristics of All Eligible and Efficacy Evaluable Patients (n = 70)
| Characteristic | Number (%) |
|---|---|
| Age (years) | |
| Median | 7.1 |
| Range | 3.3–19.4 |
| Sex | |
| Male | 32 (45.7) |
| Female | 38 (54.3) |
| Race | |
| White | 49 (70) |
| Asian | 3 (4.3) |
| American Indian or Alaska Native | 0 (0) |
| Black or African American | 8 (11.4) |
| Unknown | 10 (14.3) |
| Ethnicity | |
| Non-Hispanic | 54 (77.1) |
| Hispanic | 14 (20) |
| Unknown | 2 (2.9) |
| Diagnoses | |
| “Typical” diffuse intrinsic pontine glioma | 61 (87.1) |
| Glioblastoma | 5 (7.1) |
| Anaplastic astrocytoma | 4 (5.7) |